J&J Faces Fines Drug Case

J&J Faces Fines Drug Case

Arkansas is added to the growing list of states penalizing Johnson & Johnson based on allegations of misrepresentation of effectiveness and/or potential dangers of usage of pharmaceutical designed for the treatment of psychosis, schizophrenia and bipolar disorder. Read about this  in the article by Katie Thomas of The New York Times….